Buy (150 RUB)
Generate QR code
Open Access
Subscription or Fee Access
The health status of children born to mothers with preeclampsia
https://doi.org/10.21508/1027-4065-2022-67-2-63-70
Abstract
Purpose. Study of perinatal and neonatal outcomes in newborns born to mothers with preeclampsia.
Characteristics of children and research methods. Perinatal outcomes were analyzed in 559 mother–newborn pairs divided into 2 groups: Group 1 included 200 children to mothers with preeclampsia (143 with moderate and 57 with severe preeclampsia). Group 2 was composed of 359 newborns to mothers with a physiological course of pregnancy. The medical history, features of the course of pregnancy, delivery, and the early neonatal period were analyzed. The condition of newborns was assessed on the Apgar scale at 1 and 5 minutes, the assessment of physical development — using centile tables for full-term and premature newborns (INTERGROWTH-21st), the assessment of neuromuscular and physical maturity on the Ballard scale.
Results. The study showed that children born to mothers with preeclampsia are significantly more likely to have metabolic and hematological disorders, a higher risk of developing infectious and inflammatory diseases, and a direct correlation with the period of manifestation and severity of preeclampsia. The higher occurrence of these conditions and the structure of pathological changes in the neonatal period led to a longer stay of children of this group after birth at newborn intensive care units, and also required observation at the second stage of nursing.
Conclusion. Preeclampsia is a risk factor for neonatal complications. The identified features of adaptation in newborns from patients with preeclampsia and the structure of pathological conditions in the early neonatal period should determine the management tactics and timeliness of treatment and diagnostic measures aimed at improving the provision of medical care to the pregnant woman and subsequently the newborn.
About the Authors
A. L. Karavaeva
V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology, and Perinatology
Russian Federation
Russian Federation
Moscow
L. A. Timofeeva
V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology, and Perinatology
Russian Federation
Russian Federation
Moscow
V. V. Zubkov
V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology, and Perinatology
Russian Federation
Russian Federation
Moscow
N. E. Kan
V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology, and Perinatology; Perinatal Center of the European Medical Center
Russian Federation
Russian Federation
Moscow
V. L. Tyutyunnik
V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology, and Perinatology; Perinatal Center of the European Medical Center
Russian Federation
Russian Federation
Moscow
References
1. Paré E., Parry S., McElrath T.F., Pucci D., Newton A., Lim K.H. Clinical risk factors for preeclampsia in the 21st century. Obstet Gynecol. 2014; 124(4):763–770. DOI: 10,1097/AOG.0000000000000451
2. Hypertensive disorders during pregnancy, childbirth, and the postpartum period. Preeclampsia. Eclampsia: Federal clinical guidelines (Protocol). Moscow, 2016: 72. (in Russ.)
3. Cornelius D.C. Preeclampsia: From Inflammation to Immunoregulation. Clin Med Insights Blood Disord 2018; 11: 1179545X17752325. DOI: 10,1177/1179545X17752325
4. WHO recommendations for prevention and treatment of preeclampsia and eclampsia. 2011. https://www.ncbi.nlm.nih.gov/books/NBK140561/pdf/Bookshelf_NBK140561.pdf/ Ссылка активна на 28.02.2022.
5. Ukah U.V., De Silva D.A., Payne B., Magee L.A., Hutcheon J.A., Brown H. et al. Prediction of adverse maternal outcomes from pre-eclampsia and other hypertensive disorders of pregnancy: A systematic review. Pregnancy Hypertens 2018; 11: 115–123. DOI: 10,1016/j.preghy.2017.11.006
6. Hodzhaeva Z.S., Kogan E.A., Klimenchenko N.I., Аkat’eva А.S., Safonova А.D., Kholin А.M. et al. Clinical and pathogenetic features of early and late preeclampsia. Akusherstvo i ginecologia 2015; 1: 12–17. (in Russ.)
7. Backes C.H., Markham K., Moorehead P., Cordero L., Nankervis C.A., Giannone P.J. Maternal preeclampsia and neonatal outcomes. J Pregnancy 2011; 2011: 214365. DOI: 10,1155/2011/214365
8. Ton T.G.N., Bennett M.V., Incerti D., Peneva D., Druzin M., Stevens W. et al. Maternal and Infant Adverse Outcomes Associated with Mild and Severe Preeclampsia during the First Year after Delivery in the United States. Am J Perinatol 2020; 37(4): 398–408. DOI: 10,1055/s-0039–1679916
9. National Institute for Health and Clinical Excellence (NICE). Hypertension in pregnancy. NICE clinical guideline 107. London.: RCOG Press, 2011; 50
10. American College of Obstetricians and Gynecologists. The American College of Obstetricians and Gynecologists. Perinatal risks associated with assisted reproductive technology. Committee Opinion No. 671. Obstet Gynecol 2016; 128: e61–8. DOI: 10,1097/AOG.0000000000001643
11. Redman C.W., Sargent I.L. Latest advances in understanding preeclampsia. Science. 2005; 308(5728): 1592–1594. DOI:10,1126/science.1111726
12. Gruslin A., Lemyre B. Pre-eclampsia: Fetal assessment and neonatal outcomes. Best Pract Res Clin Obstet Gynaecol 2011; 25(4): 491–507. DOI: 10,1016/j.bpobgyn.2011.02.004
13. Timofeeva L.A., Karavaeva A.L., Zubkov V.V., Kirtbaya A.R., Kan N.E., Tyutyunnik V.L. Role of preeclampsia in pregnancy outcomes: a neonatologist’s perspective. Akusherstvo i ginecologiya 2019; 4: 73–78. (in Russ.)
14. Broekhuijsen K., van Baaren G.J., van Pampus M.G., Ganzevoort W., Sikkema J.M., Woiski M.D. et al. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. Lancet 2015; 385(9986): 2492–501. DOI: 10,1016/S0140–6736(14)61998-X
15. Saunders L., Dean L., Mary A., Dhriti M., Badri G. Pre-eclampsia has an adverse impact on maternal and fetal health. Translat Res 2015; 165(4): 449–463. DOI: 10,1016/j.trsl.2014.10.006
16. Mayrink J., Costa M.L., Cecatti J.G. Preeclampsia in 2018: Revisiting Concepts, Physiopathology, and Prediction. Scientific World J 2018; 2018: 6268276. DOI: 10,1155/2018/6268276
17. Sydsjö G., Lindell Pettersson M., Bladh M., Skoog Svanberg A., Lampic C., Nedstrand E. Evaluation of risk factors’ importance on adverse pregnancy and neonatal outcomes in women aged 40 years or older. BMC Pregnancy Childbirth 2019; 19(1): 92. DOI: 10,1186/s12884–019–2239–1
18. Miroshina E.D., Tyutyunnik N.V., Khramchenko N.V., Kharchenko D.K., Kan N.E. Diagnosis of preeclampsia att hepresentstage. Problemy reproduktsii 2017; 23(1): 96–102. (in Russ.) DOI: 10,17116/repro201723196–102
19. Mendola P., Mumford S.L., Männistö T.I., Holston A., Reddy U.M., Laughon S.K. Controlled direct effects of preeclampsia on neonatal health after accounting for mediation by preterm birth. Epidemiology 2015; 26(1): 17–26. DOI: 0,1097/EDE.0000000000000213
Review
For citations:
Karavaeva A.L., Timofeeva L.A., Zubkov V.V., Kan N.E., Tyutyunnik V.L. The health status of children born to mothers with preeclampsia. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2022;67(2):63-70. (In Russ.) https://doi.org/10.21508/1027-4065-2022-67-2-63-70
Views:
1661
Email this article 